| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/07/2013 | CN103230477A Traditional Chinese medicine for treating malignant tumor and therapeutic method |
| 08/07/2013 | CN103230467A Traditional Chinese medicine extract and preparation method thereof |
| 08/07/2013 | CN103230466A Traditional Chinese medicine extract and preparation method thereof |
| 08/07/2013 | CN103230465A Traditional chinese medicine extract |
| 08/07/2013 | CN103230456A Traditional Chinese medicine extract and preparation method thereof |
| 08/07/2013 | CN103230454A Cancer resisting and tumor restraining capsule and its preparation method |
| 08/07/2013 | CN103230451A Drug for preventing and treating cardia-cerebrovascular diseases and hepatopathy and preparation method thereof |
| 08/07/2013 | CN103230450A Traditional Chinese medicine composition and preparation method therof |
| 08/07/2013 | CN103230439A Elegant jessamine sustained-release membrane and preparation method thereof |
| 08/07/2013 | CN103230436A Traditional chinese medicine extract and preparation method thereof |
| 08/07/2013 | CN103230427A Traditional Chinese medicine extract and preparation method thereof |
| 08/07/2013 | CN103230424A Preparation method and application of ferula ferulaeoides chloroform extract |
| 08/07/2013 | CN103230417A Use of Asterias rollestoni Bell extract in preparation of antitumor drug |
| 08/07/2013 | CN103230414A Materials and methods for treating and managing angiogenesis-mediated diseases |
| 08/07/2013 | CN103230408A Method for preparing phloretin |
| 08/07/2013 | CN103230406A Application of ginsenoside Rg6 in preparation of drug for treating lymphoma |
| 08/07/2013 | CN103230401A Application of triptonide to anti-angiogenesis drugs |
| 08/07/2013 | CN103230398A Applications of a Wogonin derivative in the preparation of antineoplastic drugs |
| 08/07/2013 | CN103230394A Compositions and methods for treating neoplastic diseases |
| 08/07/2013 | CN103230390A Application of salvianolic acid B in preparing medicines used in protection of arsenic-trioxide-induced cardiotoxicity and with synergetic antitumor effect |
| 08/07/2013 | CN103230388A Application of isodon henryi as Wnt signal path inhibitor and anti-cancer drug |
| 08/07/2013 | CN103230382A Celecoxib effervescent tablet and preparation method thereof |
| 08/07/2013 | CN103230373A Dexlansoprazole freeze-drying powder for injection and preparation method thereof |
| 08/07/2013 | CN103230371A Preparation method of injection-use oxaliplatin freeze-dried preparation |
| 08/07/2013 | CN103230370A X-ray pyrogenic composite nanoparticle |
| 08/07/2013 | CN103230002A DHA (docosahexaenoic acid) liposome preparation method |
| 08/07/2013 | CN102875513B Microcrystal catechin and preparation method thereof |
| 08/07/2013 | CN102861077B Application of Houttuynoid D in medicine for treating cervical cancer |
| 08/07/2013 | CN102793677B Method for preparing gemcitabine hydrochloride lyophilized powder |
| 08/07/2013 | CN102772809B Preparation method of nano magnetic control agglomeration chemotherapeutic pharmaceutical composition |
| 08/07/2013 | CN102675655B Water-soluble fullerene and preparation and application methods thereof |
| 08/07/2013 | CN102614473B Chinese medicinal compound preparation for treating malignant solid tumor |
| 08/07/2013 | CN102614268B Chinese medicine for treating esophageal carcinoma |
| 08/07/2013 | CN102579449B Combined medicine capable of improving sensibility of tumors to paclitaxel |
| 08/07/2013 | CN102558282B 一种熊果酸衍生物及其制备方法 One kind of ursolic acid derivative and its preparation method |
| 08/07/2013 | CN102526416B Traditional Chinese medicine for treating breast carcinoma |
| 08/07/2013 | CN102503881B Optically active tryptamine derivative and synthetic method and application thereof |
| 08/07/2013 | CN102443594B Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application |
| 08/07/2013 | CN102382097B Aromatic methylamine derivative and pharmaceutical composition, preparation method and application thereof |
| 08/07/2013 | CN102335233B Polyphenol extract of trembling poplar as well as extraction method and application thereof |
| 08/07/2013 | CN102335180B Application of ursane compounds in preparing antitumor drugs |
| 08/07/2013 | CN102302554B Extraction method of schisandra total lignans |
| 08/07/2013 | CN102178948B Genetic engineering drug for treating and/or preventing cervical cancer |
| 08/07/2013 | CN102172410B Construction method of targeted nano particle transmission system for cancer diagnosis and treatment |
| 08/07/2013 | CN102037058B Docetaxel polymer derivative, method for producing same and use of same |
| 08/07/2013 | CN102036988B Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 08/07/2013 | CN102036962B Combined use of angiogenesis inhibitor and taxane |
| 08/07/2013 | CN101941914B Hydroxyl whole-protection didecyl quaternary ammonium with anti-tumor activity and preparation method thereof |
| 08/07/2013 | CN101928322B Ursolic acid modifier polyol monoesters with anti-cancer activity |
| 08/07/2013 | CN101845438B Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 08/07/2013 | CN101745102B Composition of 5-aminolevulinic acid and derivative thereof as well as application thereof |
| 08/07/2013 | CN101703490B Polysaccharide/inorganic nanoparticles hybrid micron-nano medicine-carrying capsule |
| 08/07/2013 | CN101511841B Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors |
| 08/07/2013 | CN101450215B Polylactic acid-glycolic acid co-polymer nanometer granule with immunotoxin out-connection antibody inside |
| 08/07/2013 | CN101395183B Anti-ephb4 antibodies and methods using same |
| 08/07/2013 | CN101379089B Anti-ilt7 antibody |
| 08/07/2013 | CN101312989B Monoclonal antibodies against claudin-18 for treatment of cancer |
| 08/07/2013 | CN101080222B Chemically stable compositions of 4-hydroxy tamoxifen |
| 08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
| 08/06/2013 | US8501936 Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives |
| 08/06/2013 | US8501934 Pyrrolobenzodiazepines |
| 08/06/2013 | US8501912 Filipil compositions and methods for treating cancer |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501731 Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity |
| 08/06/2013 | US8501728 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2013 | US8501717 Methods to treat and/or prevent mucositis |
| 08/06/2013 | US8501678 Variant activin receptor polypeptides and uses thereof |
| 08/06/2013 | US8501677 Methods and compositions for modulating T cell and/or B cell activation |
| 08/06/2013 | US8501423 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | US8501171 Use of ADCC-optimized antibodies for treating weak patients |
| 08/06/2013 | US8501166 Pyrimidinyl indole compounds |
| 08/06/2013 | CA2752421C Amino ester derivatives, salts thereof and methods of use |
| 08/06/2013 | CA2732620C Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 08/06/2013 | CA2625741C Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde |
| 08/06/2013 | CA2599124C Imidazo (1,2-a) pyridine compounds as vegf-r2 inhibitors |
| 08/06/2013 | CA2564784C Episomal fusion gene |
| 08/06/2013 | CA2532865C Fluoro substituted omega-carboxyaryl diphenyl urea for the inhibition of kinase signaling |
| 08/06/2013 | CA2531859C Benzimidazole derivatives as raf kinase inhibitors |
| 08/06/2013 | CA2526509C Connective tissue growth factor antibodies |
| 08/06/2013 | CA2522580C A medicament for the two-step perioperative therapy of solid tumours |
| 08/06/2013 | CA2489214C Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 08/06/2013 | CA2425779C Compositions that inhibit proliferation of cancer cells |
| 08/06/2013 | CA2388807C Viruses for the treatment of cellular proliferative disorders |
| 08/06/2013 | CA2326685C Enhancing immune responses to genetic immunization by using a chemokine |
| 08/01/2013 | WO2013113030A2 Fads regulation |
| 08/01/2013 | WO2013112881A1 Mct protein inhibitor-related prognostic and therapeutic methods |
| 08/01/2013 | WO2013112878A1 Mcl-1 modulating compositions |
| 08/01/2013 | WO2013112856A2 Multifunctional nanomaterials for the treatment of cancer |
| 08/01/2013 | WO2013112722A1 Inhibitors of rho associated protein kinases (rock) and methods of use |
| 08/01/2013 | WO2013112186A2 Organometallic anti-cancer complexes |
| 08/01/2013 | WO2013111897A1 Novel antitumor agent and method for screening same |
| 08/01/2013 | WO2013111831A1 Pyrrole compound |
| 08/01/2013 | WO2013111770A1 Novel anti-malignant tumor agent |
| 08/01/2013 | WO2013111132A1 Treatment of liver conditions |
| 08/01/2013 | WO2013111105A1 Imidazopyrrolidinone compounds |
| 08/01/2013 | WO2013110890A1 New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/01/2013 | WO2013110796A1 Thiazolidinedione derivatives, preparation thereof and use thereof in cancer treatment |
| 08/01/2013 | WO2013110704A1 Novel galactoside inhibitors of galectins |
| 08/01/2013 | WO2013110681A1 Chitosan covalently linked with small molecule integrin antagonist for targeted delivery |